L’équipe C.A.C Lauriane
Une équipe d’experts engagés pour accompagner les pharmaciens dans l’amélioration de la gestion et de la performance de leurs officines.
Dr. Elena Vance
Regulatory Strategy Lead
Dr. Vance brings over 15 years of experience in navigating global FDA and EMA pathways for complex drug approvals and biological redressing.
Robert Chen
Pharmacovigilance Advisor
Robert ensures operational excellence and compliance with international safety reporting standards and risk management implementation.
Marcus Thorne
Market Access Director
Marcus specializes in navigating reimbursement landscapes and developing robust pricing strategies for orphan drugs and innovative biologics.
Dr. Amara Okafor
Clinical Development Consultant
Dr. Okafor provides high-level strategic oversight to help optimize clinical trial designs while meeting rigorous regulatory requirements.
Sarah J. Miller, PhD
HEOR Specialist
Sarah applies rigorous economic modeling and clinical data synthesis to demonstrate product therapeutic value to global health payers.
Julian Rossi
Biostatistics Associate
Julian provides expert statistical analysis to support clinical evidence packages for mid-to-late stage pharmaceutical drug assets.
Regulatory Strategy
We specialize in navigating the intricate landscape of global health authorities, ensuring strategic alignment from clinical development through global approval phases.
HEOR
Leveraging sophisticated modeling and real-world evidence to communicate the clinical superiority and economic value of breakthroughs to payers and providers.
Global Expertise Across the Pharmaceutical Lifecycle
Our unified expertise ensures your drug assets navigate the complexities of modern medicine with strategic precision and operational excellence.
Market Access
Delivering integrated value evidence and reimbursement strategies to optimize product positioning and clinical adoption across diverse international healthcare markets.
Pharmacovigilance
Establishing rigorous safety monitoring systems and high-level risk management protocols to ensure total compliance with evolving international drug safety standards.
Ready to Advance Your Strategy?
Contact our consultants today